Global approaches to the role of miRNAs in drug-induced changes in gene expression

Frontiers in Genetics

Volumn 3, Issue JUN, 2012, Pages

  Eipper Mains, Jodi E ^a   Eipper, Betty A ^a   Mains, Richard E ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cell adhesion; Cocaine; Micrornas; miR 8; Postsynaptic density; RNA seq; Synaptic plasticity

Indexed keywords

EID: 84872675044     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2012.00109     Document Type: Review

References (154)

1. Albertson, D. N., Pruetz, B., Schmidt, C. J., Kuhn, D. M., Kapatos, G., and Bannon, M. J. (2004). Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J. Neurochem. 88, 1211-1219.
2. Anderson, S. M., Famous, K. R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H. D., Bass, C. E., Terwilliger, E. F., Cha,J.-H.J., and Pierce, R. C. (2008). CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat. Neurosci. 11,344-353.
3. Ashraf, S. I., McLoon, A. L., Sclarsic, S. M., and Kunes, S. (2006). Synaptic protein synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cell 124, 191-205.
4. Banerjee, S., Neveu, P., and Kosik, K. S. (2009). A coordinated local translational control point at the synapse involving relief from silencing and MOV10 degradation. Neuron 64, 871-884.
5. Bannon, M., Kapatos, G., and Albertson, D. (2005). Gene expression profiling in the brains of human cocaine abusers. Addict. Biol. 10, 119-126.
6. Benavides, D. R., Quinn, J. J., Zhong, P., Hawasli, A. H., DiLeone, R. J., Kansy, J. W., Olausson, P., Yan, Z., Taylor, J. R., and Bibb, J. A. (2007). Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. J. Neurosci. 27, 12967-12976.
7. Berke, J. D., and Hyman, S. E. (2000). Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25, 515-532.
8. Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A., and Cairns, M. J. (2010). Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 15,1176-1189.
9. Brenner, S., Johnson, M., Bridgham, J., Golda, G., Lloyd, D. H., Johnson, D., Luo, S., McCurdy, S., Foy, M., Ewan, M., Roth, R., George, D., Eletr, S., Albrecht, G., Vermaas, E., Williams, S. R., Moon, K., Burcham, T., Pallas, M., DuBridge, R. B., Kirchner, J.,Fearon, K., Mao, J., and Corcoran, K. (2000). Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat. Biotechnol. 18, 630-634.
10. Broderick, J. A., Salomon, W. E., Ryder, S. P., Aronin, N., and Zamore, P. D. (2011). Argonaute protein identity and pairing geometry determine cooperativity in mammalian RNA silencing. RNA 17, 1858-1869.
11. Castner, S. A., and Goldman-Rakic, P. S. (1999). Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys. Neuropsychopharmacology20, 10-28.
12. Chandrasekar, V., and Dreyer, J.-L. (2009). microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity. Mol. Cell. Neurosci. 42, 350-362.
13. Chandrasekar, V., and Dreyer, J.-L. (2011). Regulation of MiR-124, Let-7d, and MiR-181a in the accum-bens affects the expression, extinction, and reinstatement of cocaine-induced conditioned place preference. Neuropsychopharmacology 36, 1149-1164.
14. Cloonan, N., Forrest, A. R. R., Kolle, G., Gardiner, B. B. A., Faulkner, G. J., Brown, M. K., Taylor, D. F., Steptoe, A. L., Wani, S., Bethel, G., Robertson, A. J., Perkins, A. C., Bruce, S. J., Lee, C.C., Ranade, S. S., Peckham, H. E., Manning, J. M., McKernan, K. J., and Grimmond, S. M. (2008). Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat. Meth ods 5,613-619.
15. Conn, P. J., Battaglia, G., Marino, M. J., and Nicoletti, E (2005). Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat. Rev. Neurosci. 6, 787-798.
16. Crespo, J. A., Manzanares, J., Oliva, J. M., Corchero, J., Palomo, T., and Ambrosio, E. (2001). Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain. Neuropsychopharmacology 25, 185-194.
17. Curran, E. J., and Watson, S. J. (1995). Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. J. Comp. Neurol. 361, 57-76.
18. Czech, B., and Hannon, G. J. (2011). Small RNA sorting: matchmaking for Argonautes. Nat. Rev. Genet. 12, 19-31.
19. Daunais, J. B., Nader, M. A., and Porrino, L. J. (1997). Long-term cocaine self-administration decreases striatal preproenkephalin mRNA in rhesus monkeys. Pharmacol. Biochem. Behav. 57,471-475.
20. De, N., and MacRae, I. J. (2011). Purification and assembly of human Argonaute, Dicer, and TRBP complexes. Methods Mol. Biol. 725,107-119.
21. Dennis, G., Sherman, B. T., Hosack, D.A., Yang, J., Gao, W., Lane, H. C., and Lempicki, R. A.(2003). DAVID:database for annotation, visualization, and integrated discov ery. Genome Biol. 4, P3.
22. Di Chiara, G. (2002). Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav. Brain Res. 137, 75-114.
23. Eipper-Mains, J. E., Kiraly, D. D., Palakodeti, D., Mains, R. E., Eipper, B. A., and Graveley, B. R. (2011). microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA 17, 1529-1543.
24. Ender, C., and Meister, G. (2010). Argonaute proteins at a glance. J. Cell. Sci. 123, 1819-1823.
25. Esteller, M. (2011). Non-coding RNAs in human disease. Nat. Rev. Genet. 12, 861-874.
26. Frost, R. J. A., and Olson, E. N. (2011). Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc. Natl. Acad. Sci. U.S.A. 108, 21075-21080.
27. Fu, X., Fu, N., Guo, S., Yan, Z.,Xu, Y., Hu, H., Menzel, C., Chen, W., Li, Y., Zeng, R., and Khaitovich, P. (2009). Estimating accuracy of RNA-Seq and microarrays with proteomics. BMC Genomics 10,161. doi:10.1186/1471-2164-10-161
28. Graham, D. L., Krishnan, V., Larson, E. B., Graham, A., Edwards,S.,Bachtell, R. K., Simmons, D., Gent, L. M., Berton, O., Bolanos, C. A., DiLeone, R. J., Parada, L. F., Nestler, E. J., and Self, D. W. (2009). Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward. Biol. Psychiatry 65,696-701.
29. Graveley, B. R. (2008). Molecular biology: power sequencing. Nature 453, 1197-1198.
30. Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., and Enright, A. J. (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34, D140-D144.
31. Griffiths-Jones, S., Saini, H. K., van Dongen, S., and Enright, A. J. (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res. 36,D154-D158.
32. Guo, H., Ingolia, N. T., Weissman, J. S., and Bartel, D. P. (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840.
33. Guo, Y., Chen, Y., Carreon, S., and Qiang, M. (2012). Chronic intermittent ethanol exposure and its removal induce a different miRNA expression pattern in primary cortical neuronal cultures. Alcohol Clin. Exp. Res. 36, 1058-1066.
34. Hansen, K. D., Brenner, S. E., and Dudoit, S. (2010). Biases in Illumina transcriptome sequencing caused by random hexamer priming. Nucleic Acids Res. 38,e131.
35. Hayden,E.C.(2012). Nanopore genome sequencer makes its debut. Nature doi:10.1038/nature.2012.10051
36. He, Y., Yang, C., Kirkmire, C. M., and Wang, Z. J. (2010). Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J. Neurosci. 30, 10251-10258.
37. Helwig, M., Lee, S.-N., Hwang, J. R., Ozawa, A., Medrano, J. F., and Lind-berg, I. (2011). Dynamic modulation of prohormone convertase 2 (PC2)-mediated precursor processing by 7B2 protein: preferential effect on glucagon synthesis. J. Biol. Chem. 286,42504-42513.
38. Henry, J. C., Azevedo-Pouly, A. C. P., and Schmittgen, T. D. (2011). MicroRNA replacement therapy for cancer. Pharm. Res. 28, 3030-3042.
39. Höck, J., and Meister, G. (2008). The Argonaute protein family. Genome Biol. 9,210.
40. Hollander, J. A., Im, H.-I., Amelio, A. L., Kocerha, J., Bali, P., Lu, Q., Willoughby, D., Wahlestedt, C., Conkright, M. D., and Kenny, P. J. (2010). Striatal microRNA controls cocaine intake through CREB signalling. Nature 466, 197-202.
41. Hu,G.,Wei,Y.,and Kang,Y. (2009).The multifaceted role of MTDH/AEG-1 in cancer progression. Clin. Cancer Res. 15, 5615-5620.
42. Hubert, G. W., Jones, D. C., Moffett, M. C., Rogge, G., and Kuhar, M. J. (2008). CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochem. Pharmacol. 75, 57-62.
43. Hyman, S. E., and Malenka, R. C. (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695-703.
44. Hyman, S. E., Malenka, R. C., and Nestler, E. J. (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565-598.
45. Illumina. (2011).Technology: History of Solexa Sequencing. Available at: http://www.illumina.com [accessed May 13,2011].
46. Im, H.-I., Hollander, J. A., Bali, P., and Kenny, P. J. (2010). MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat. Neurosci. 13, 1120-1127.
47. Inui, M., Martello, G., and Piccolo, S. (2010). MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11,252-263
48. Kalivas, P. W (2009). The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 10,561-572.
49. Kalivas, P. W., Volkow, N., and Seamans, J. (2005). Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 45, 647-650.
50. Kanehisa, M., and Goto, S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27-30.
51. Kang, D.-C., Su, Z.-Z., Sarkar, D., Emdad, L., Volsky, D. J., and Fisher, P. B. (2005). Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353, 8-15.
52. Kauer, J. A., and Malenka, R. C. (2007). Synaptic plasticity and addiction. Nat. Rev. Neurosci. 8, 844-858.
53. Kiebler, M. A., and DesGroseillers, L. (2000). Molecular insights into mRNA transport and local translation in the mammalian nervous system. Neuron 25,19-28.
54. Kim, J., Krichevsky, A., Grad, Y., Hayes, G. D., Kosik, K. S., Church, G. M., and Ruvkun, G. (2004). Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc. Natl. Acad. Sci. U.S.A. 101,360-365.
55. Kim, V. N., Han, J., and Siomi, M. C. (2009). Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139.
56. Kiraly, D. D., Ma, X.-M., Mazzone, C. M., Xin, X., Mains, R. E., and Eipper, B. A. (2010a). Behavioral and morphological responses to cocaine require kalirin7. Biol. Psychiatry 68, 249-255.
57. Kiraly, D. D., Eipper-Mains, J. E., Mains, R. E., and Eipper, B. A. (2010b). Synaptic plasticity, a symphony in GEF. ACS Chem. Neurosci. 1, 348-365.
58. Koob, G. F., and Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24, 97-129.
59. Krichevsky, A. M., King, K. S., Donahue, C. P., Khrapko, K., and Kosik, K. S. (2003). A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9, 1274-1281.
60. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., and Tuschl, T. (2002). Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739.
61. Landgraf, P., Rusu, M., Sheridan, R., Sewer,A.,Iovino,N.,Aravin,A.,Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., Lin, C., Socci, N. D., Hermida, L., Fulci, V., Chiaretti,S., Foà, R., Schliwka, J., Fuchs, U., Novosel, A., Müller, R.-U., Schermer, B., Bissels, U., Inman, J., Phan, Q., Chien, M., Weir, D. B., Choksi,R., de Vita, G., Frezzetti, D., Trompeter, H.-I., Hornung, V., Teng, G., Hartmann, G., Palkovits, M., di Lauro, R., Wernet, P., Macino, G., Rogler, C.E., Nagle, J. W., Ju, J., Papavasiliou, F. N., Benzing, T., Lichter, P., Tam, W., Brownstein, M. J., Bosio, A., Borkhardt, A., Russo, J. J., Sander, C., Zavolan,M.,andTuschl,T. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
62. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S. L. (2009). Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25.
63. Law, P. T.-Y., and Wong, N. (2011). Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 26, 437-449.
64. Lehrmann, E., Oyler, J., Vawter, M. P., Hyde, T. M., Kolachana, B., Kleinman, J. E., Huestis, M. A., Becker, K. G., and Freed, W. J. (2003). Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 3,27-40.
65. Levin, J. Z., Yassour, M., Adiconis, X., Nusbaum, C., Thompson, D. A., Friedman, N., Gnirke, A., and Regev, A. (2010). Comprehensive comparative analysis of strand-specific RNA sequencing methods. Nat. Methods 7,709-715.
66. Lewohl, J. M., Nunez, Y. O., Dodd, P. R., Tiwari, G. R., Harris, R. A., and May-field, R. D. (2011). Up-regulation of MicroRNAs in brain of human alcoholics. Alcohol. Clin. Exp. Res. 35, 1928-1937.
67. Li, C.-Y., Mao, X., and Wei, L. (2008). Genes and (common) pathways underlying drug addiction. PLoS Comput. Biol. 4, e2. doi:10.1371/journal.pcbi.0040002
68. Li, H., Kloosterman, W., and Fekete, D.M. (2010). MicroRNA-183 fam ily members regulate sensorineural fates in the inner ear. J. Neurosci. 30, 3254-3263.
69. Li, M. D., and van der Vaart, A. D. (2011). MicroRNAs in addiction: adaptation's middlemen Mol. Psychiatry 16, 1159-1168.
70. Li,X., and Jin, P. (2009). Macro role(s) of microRNAs in fragile X syndrome Neuromolecular Med. 11,200-207.
71. Lippi, G., Steinert, J. R., Marczylo, E. L., D'Oro, S., Fiore, R., Forsythe, I. D., Schratt, G., Zoli, M., Nicotera, P.,and Young, K. W (2011). Targeting of the Arpc3 actin nucleation factor by miR-29a/b regulates dendritic spine morphology. J. Cell Biol. 194, 889-904.
72. Liu, X.-Y., Mao, L.-M., Zhang, G.-C., Papasian, C. J., Fibuch, E. E., Lan, H.-X., Zhou, H.-F., Xu, M., and Wang, J. Q. (2009). Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII. Neuron 61, 425-438.
73. Lobo, M. K., Covington, H. E., Chaud-hury, D., Friedman, A. K., Sun, H., Damez-Werno, D., Dietz, D. M., Zaman, S., Koo, J. W., Kennedy, P. J., Mouzon, E., Mogri, M., Neve, R. L., Deisseroth, K., Han, M.-H., and Nestler, E. J. (2010). Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330, 385-390.
74. Lugli, G., Larson, J., Martone, M. E., Jones, Y., and Smalheiser, N. R. (2005). Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner. J. Neurochem. 94, 896-905.
75. Lugli, G., Torvik, V. I., Larson, J., and Smalheiser, N. R. (2008). Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain. J. Neurochem. 106, 650-661.
76. Ma, X.-M., Kiraly, D. D., Gaier, E. D., Wang, Y., Kim, E.-J., Levine, E. S., Eipper, B. A., and Mains, R. E. (2008). Kalirin-7 is required for synaptic structure and function. J. Neurosci. 28,12368-12382.
77. Mains, R. E., Kiraly, D. D., Eipper-Mains, J. E., Ma, X., and Eipper, B. A. (2011). Kalrn promoter usage and isoform expression respond to chronic cocaine exposure. BMCNeurosci. 12, 20. doi:10.1186/1471-2202-12-20
78. Margulies, M., Egholm, M., Altman, W. E., Attiya, S., Bader, J. S., Bemben, L. A., Berka, J., Braverman, M. S., Chen, Y.-J., Chen, Z., Dewell, S. B., Du, L., Fierro, J. M., Gomes, X. V., Godwin, B. C., He, W., Helgesen, S., Ho, C. H., Ho, C. H., Irzyk, G. P., Jando, S. C., Alenquer, M. L. I., Jarvie, T. P., Jirage, K. B., Kim, J.-B., Knight, J. R., Lanza, J. R., Leamon, J. H., Lefkowitz, S. M., Lei, M., Li, J., Lohman, K. L., Lu, H., Makhijani, V. B., McDade, K. E., McKenna, M. P., Myers, E. W., Nickerson, E., Nobile, J. R., Plant, R., Puc, B. P., Ronan, M. T., Roth, G. T., Sarkis, G. J., Simons, J. F., Simpson, J. W., Srinivasan, M., Tartaro, K. R., Tomasz, A., Vogt, K. A., Volkmer, G. A., Wang, S. H.,Wang, Y., Weiner, M. P., Yu, P., Begley, R. F., and Rothberg, J. M. (2005). Genome sequencing in microfabricated high-density picolitre reactors. Nature 437, 376-380.
79. Martí, E., Pantano, L., Bañez-Coronel, M., Llorens, F., Miñones-Moyano, E., Porta, S., Sumoy, L., Ferrer, I., and Estivill, X. (2010). A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 38, 7219-7235.
80. Martinek, S., and Gaul, U. (1997). Neural development: how cadherins zipper up neural circuits. Curr. Biol. 7, R712-R715.
81. Mash, D. C., Ffrench-Mullen, J., Adi, N., Qin, Y., Buck, A., and Pablo, J. (2007). Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. PLoS ONE 2, e1 187. doi:10.1371/journal.pone.0001187
82. Mash, D. C., Ouyang, Q., Pablo, J., Basile, M., Izenwasser, S., Lieberman, A., and Perrin, R. J. (2003). Cocaine abusers have an over-expression of alpha-synuclein in dopamine neurons. J. Neurosci. 23, 2564-2571.
83. Maxam, A. M., and Gilbert, W (1977). A new method for sequencing DNA. Proc. Natl. Acad. Sci. U.S.A. 74, 560-564.
84. McCarty, M. F. (2012). Metformin may antagonize Lin28 and/or Lin28B activity, thereby boosting let-7 levels and antagonizing cancer progression. Med. Hypotheses 78, 262-269.
85. McClung, C. A., and Nestler, E. J. (2003). Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat. Neurosci. 6, 1208-1215.
86. McClung, C. A., and Nestler, E. J. (2008). Neuroplasticity mediated by altered gene expression. Neuropsychophar-macology 33, 3-17.
87. Metzker, M. L. (2010). Sequencing technologies-the next generation. Nat. Rev. Genet. 11,31-46.
88. Miska, E. A., Alvarez-Saavedra, E., Townsend, M., Yoshii, A., Sestan, N., Rakic, P., Constantine-Paton, M., and Horvitz, H. R. (2004). Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 5, R68.
89. Mongroo, P. S., and Rustgi, A. K. (2010). The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol. Ther. 10,219-222.
90. Morabito, M. A., Sheng, M., and Tsai, L.-H. (2004). Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J. Neurosci. 24, 865-876.
91. Moreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., and Brzustowicz, L. M. (2011). Altered MicroRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 69,188-193.
92. Mortazavi, A., Williams, B. A., McCue, K.,Schaeffer,L.,andWold,B. (2008). Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628.
93. Nestler, E. J. (2001). Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128.
94. Nestler, E. J. (2005a). The neurobiology of cocaine addiction. Sci. Pract. Perspect. 3,4-10.
95. Nestler, E. J. (2005b). Is there a common molecular pathway for addiction Nat. Neurosci. 8, 1445-1449.
96. Nestler, E. J., and Aghajanian, G. K. (1997). Molecular and cellular basis of addiction. Science 278, 58-63.
97. Norrholm, S. D., Bibb, J. A., Nestler, E. J., Ouimet, C. C., Taylor, J. R., and Greengard, P. (2003). Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 116, 19-22.
98. Oshlack, A., and Wakefield,M.J. (2009). Transcript length bias in RNA-seq data confounds systems biology. Biol. Direct 4, 14.
99. Ozsolak, F., and Milos, P. M. (2011). RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 12, 87-98.
100. Pan, H., Che, F.-Y., Peng, B., Steiner, D. F., Pintar, J. E., and Fricker, L. D. (2006). The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic study. J. Neurochem. 98, 1763-1777.
101. Paulson, P. E., Camp, D. M., and Robinson, T. E. (1991). Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology (Berl.) 103,480-492.
102. Pietrzykowski, A. Z., Friesen, R. M., Martin, G. E., Puig, S. I., Nowak, C. L., Wynne, P. M., Siegelmann, H. T., and Treistman, S. N. (2008). Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol. Neuron 59,274-287.
103. Przewlocka, B., and Lason, W. (1995). Adaptive changes in the proenkephalin and D2 dopamine receptor mRNA expression after chronic cocaine in the nucleus accumbens and striatum of the rat. Eur. Neuropsychopharmacol. 5, 465-469.
104. Rao, A., and Steward, O. (1991). Evidence that protein constituents of postsynaptic membrane specializations are locally synthesized: analysis of proteins synthesized within synaptosomes.J. Neurosci. 11, 2881-2895.
105. Robinson, T. E., and Berridge, K. C. (2001). Incentive-sensitization and addiction. Addiction 96, 103-114.
106. Robinson, T. E., Gorny, G., Mitton, E., and Kolb, B. (2001). Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39, 257-266.
107. Robinson, T. E., and Kolb, B. (1997). Persistent structural modifications in nucleus accumbens and pre-frontal cortex neurons produced by previous experience with amphetamine.J. Neurosci. 17, 8491-8497.
108. Robinson, T. E., and Kolb, B. (1999). Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11, 1598-1604.
109. Ross, S., and Peselow, E. (2009). The neurobiology of addictive disorders. Clin. Neuropharmacol. 32,269-276.
110. Rossman, K. L., Der, C. J., and Sondek, J. (2005). GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev. Mol. Cell Biol. 6, 167-180.
111. Roush, S., and Slack, F. J. (2008). The let-7 family of microRNAs. Trends Cell Biol. 18,505-516.
112. Saba,R.,Störchel,P.H.,Aksoy-Aksel,A., Kepura, F., Lippi, G., Plant, T. D., and Schratt, G. M. (2012). Dopamine-regulatedmicroRNAMiR-18 1a controls GluA2 surface expression in hippocampal neurons. Mol. Cell. Biol. 32, 619-632.
113. Sanchez-Simon, F. M., Zhang, X. X., Loh, H. H., Law, P.-Y., and Rodriguez, R. E. (2010). Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol. Pharmacol. 78, 935-942.
114. Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74, 5463-5467.
115. Santarelli, D. M., Beveridge, N. J., Tooney, P. A., and Cairns, M. J.(2011). Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 69,180-187.
116. Schaefer, A., Im, H.-I., Venø, M. T., Fowler, C. D., Min, A., Intrator, A., Kjems, J., Kenny, P. J., O'Carroll, D., and Greengard,P. (2010).Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. J. Exp.Med. 207, 1843-1851.
117. Schratt, G. (2009a). Fine-tuning neural gene expression with microRNAs. Curr. Opin. Neurobiol. 19, 213-219.
118. Schratt, G. (2009b). microRNAs at the synapse. Nat. Rev. Neurosci. 10, 842-849.
119. Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., and Greenberg, M. E. (2006). A brain-specific microRNA regulates dendritic spine development. Nature 439,283-289.
120. Self, D. W., and Nestler, E. J. (1995). Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18,463-495.
121. Shendure, J. (2008). The beginning of the end for microarrays Nat. Methods 5, 585-587.
122. Shendure, J., Porreca, G. J., Reppas, N. B., Lin, X., McCutcheon, J. P., Rosenbaum, A. M., Wang, M. D., Zhang, K., Mitra, R. D., and Church, G. M. (2005). Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309, 1728-1732.
123. Siegel, G., Obernosterer, G., Fiore, R., Oehmen, M., Bicker, S., Christensen, M., Khudayberdiev, S., Leuschner, P. F.,Busch, C. J. L., Kane, C, Hiibel, K., Dekker, F., Hedberg, C., Rengarajan, B., Drepper, C., Waldmann, H., Kauppinen, S., Greenberg, M. E., Draguhn, A., Rehmsmeier, M., Martinez, J., and Schratt, G. M.(2009).A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat. Cell Biol. 11,705-716.
124. Siegel, G., Saba, R., and Schratt, G. (2011). microRNAs in neurons: manifold regulatory roles at the synapse. Curr. Opin. Genet. Dev. 21, 491-497.
125. Song, J.-J., Smith, S. K., Hannon, G. J., and Joshua-Tor, L.(2004). Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305, 1434-1437.
126. Spangler, R., Ho, A., Zhou, Y., Maggos, C. E., Yuferov, V., and Kreek, M. J. (1996). Regulation of kappa opioid receptor mRNA in the rat brain by binge pattern cocaine administration and correlation with prepro-dynorphin mRNA. Brain Res. Mol. Brain Res. 38, 71-76.
127. Suzuki, T., Tian, Q. B., Kuromitsu, J., Kawai, T., and Endo, S. (2007). Characterization of mRNA species that are associated with postsynaptic density fraction by gene chip microarray analysis. Neurosci. Res. 57, 61-85.
128. Tang, L., Hung, C. P., and Schuman, E. M. (1998). A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation. Neuron 20, 1165-1175.
129. Thomas, P. D., Campbell, M. J., Kejariwal, A., Mi, H., Karlak, B., Daverman, R., Diemer, K., Muruganujan, A., and Narechania, A. (2003). PANTHER: a library of protein families and subfamilies indexed by function. GenomeRes. 13, 2129-2141.
130. Trapnell, C., Pachter, L., and Salzberg, S. L. (2009). TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111.
131. Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., and Pachter, L. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515.
132. Treistman, S. N., and Martin, G. E. (2009). BK channels: mediators and models for alcohol tolerance. Trends Neurosci. 32, 629-637.
133. Urdinguio, R. G., Fernandez, A. F., Lopez-Nieva, P., Rossi, S., Huertas, D., Kulis, M., Liu, C.-G., Croce, C., Calin, G. A., and Esteller, M. (2010). Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 5, 656-663.
134. Vo, N. K., Cambronne, X. A., and Goodman, R. H. (2010). MicroRNA pathways in neural development and plasticity. Curr. Opin. Neurobiol. 20, 457-465.
135. Volkow, N. D., Fowler, J. S., Wang, G.-J., and Swanson, J. M. (2004). Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 9, 557-569.
136. Wahlstedt, H., Daniel, C., Ensterö, M., and Ohman, M. (2009). Large-scale mRNA sequencing determines global regulation of RNA editing during brain development. Genome Res. 19, 978-986.
137. Wang, D. O., Kim, S. M., Zhao, Y., Hwang, H., Miura, S. K.,Sossin, W S., and Martin, K. C. (2009a). Synapse-and stimulus-specific local translation during long-term neuronal plasticity. Science 324, 1536-1540.
138. Wang, Z., Gerstein, M., and Snyder, M. (2009b). RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57-63.
139. Wang, E., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S., Schroth, G., and Burge, C. (2008a). Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476.
140. Wang, X., Sun, Q., McGrath, S. D., Mardis, E. R., Soloway, P. D., and Clark, A. G. (2008b). Transcriptome-wide identification of novel imprinted genes in neonatal mouse brain. PLoS ONE 3, e3839. doi:10.1371/journal.pone.0003839
141. Wayman, G. A., Davare, M., Ando, H., Fortin, D., Varlamova, O., Cheng, H.-Y. M., Marks, D., Obrietan, K., Soderling, T. R., Goodman, R. H., and Impey, S. (2008). An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. U.S.A. 105, 9093-9098.
142. Weston, M. D., Pierce, M. L., Jensen-Smith, H. C., Fritzsch, B., Rocha-Sanchez, S., Beisel, K. W., and Soukup, G. A. (2011). MicroRNA-183 family expression in hair cell development and requirement of microRNAs for hair cell maintenance and survival. Dev. Dyn. 240, 808-819.
143. Winsky-Sommerer, R., Benjannet, S., Rovère, C., Barbero, P., Seidah, N. G., Epelbaum, J., and Dournaud, P. (2000). Regional and cellular localization of the neuroendocrine pro-hormone convertases PC1 and PC2 in the rat central nervous system. J. Comp. Neurol. 424,439-460.
144. Wise, R. A. (1996). Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19,319-340.
145. Wise, R. A. (2002). Brain reward circuitry insights from unsensed incentives. Neuron 36, 229-240.
146. Wise, R. A. (2004). Dopamine, learning and motivation. Nat. Rev. Neurosci. 5, 483-494.
147. Wolf, M. E. (2006). Addiction, in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, Vol. 7, eds G. J. Siegel, B. W. Agranoff, R. W Albers, S. K. Fisher, and M. D. Uhler (New York: American Society for Neurochemistry), 911-926.
148. Wu, H., Tao, J., Chen, P. J., Shahab, A., Ge, W., Hart, R. P., Ruan, X., Ruan, Y., and Sun, Y.E. (2010). Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. U.S.A. 107, 18161-18166.
149. Wu, Q., Zhang, L., Law, P.-Y., Wei, L.-N., and Loh, H. H. (2009). Long-term morphine treatment decreases the association of muopioid receptor (MOR1) mRNA with polysomes through miRNA23b. Mol. Pharmacol. 75, 744-750.
150. Yadav, S., Pandey, A., Shukla, A., Talwelkar, S. S., Kumar, A., Pant, A. B., and Parmar, D. (2011). miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. J. Biol. Chem. 286,37347-37357.
151. Yamagata, K., Andreasson, K. I., Sugiura, H., Maru, E., Dominique, M., Irie, Y., Miki, N., Hayashi, Y., Yoshioka, M., Kaneko, K., Kato, H., and Worley, P. F. (1999). Arcadlin is a neural activity-regulated cadherin involved in long term potentiation. J. Biol. Chem. 274,19473-11979.
152. Zheng, H., Chu, J., Zeng, Y., Loh, H. H., and Law, P.-Y. (2010). Yin Yang 1 phosphorylation contributes to the differential effects of muopioid receptor agonists on microRNA-190 expression. J. Biol. Chem. 285, 21994-22002.
153. Zhu, Q., Sun, W., Okano, K., Chen, Y., Zhang, N., Maeda, T., and Palczewski, K. (2011). Sponge transgenic mouse model reveals important roles for the microRNA-183 (miR-183)/96/182 cluster in postmitotic photoreceptors of the retina. J. Biol. Chem. 286, 31749-31760.
154. Zukin, R. S., Richter, J. D., and Bagni, C. (2009). Signals, synapses, and synthesis: how new proteins control plasticity. Front. Neural Circuits 3:14. doi:10.3389/neuro.04.014.2009